Cambridge Healthtech Institute’s 10th International

Leaders in Biobanking Congress

Innovations to Maintain Integrity and Maximize Investment in Biospecimens

October 14-16, 2018

Today, biospecimen collections are used by multiple research groups for various aims, from basic research through clinical trials. Useful biosamples must be collected to maintain their molecular integrity for specific (or unknown) downstream analysis. Thus, during research, biobanks are key infrastructures because at one time or another, these biospecimens have been stored in a biobank. Cambridge Healthtech Institute’s Tenth International Leaders in Biobanking Congress addresses innovations in biospecimen science and infrastructure to support expanding applications. Maintaining the integrity of biospecimens allows biomedical and biopharmaceutical researchers, regulators, biorepository managers, and practitioners to investigate the best strategies for effective use of biospecimens within today’s cutting-edge biomedical research.

Innovations covered include:


BIOSPECIMEN SCIENCE: MAINTAINING INTEGRITY


Preparing the Biospecimen
Collection
Processing
Isolation
Storage
Purification
Preservation
Case studies

Types of Biosamples
Legacy collections
Specialty collections
Biofluids
Fixed tissue
Frozen tissue
Donors
Disease indications

BIOBANKING MANAGEMENT: MAXIMIZING INVESTMENT


Resources
Scheduling and procurement
Collection and annotation
Specimen processing
Biopreservation protocols
Storage and backup
Requisition and withdrawal
Shipping and distribution 

Automation
Informatics tools
Inventory control
Tracking and shipping
Databases
Infrastructure and hardware
LIMS
Data integration

Regulations
Chain of custody
Informed consent
Compliance
International harmony
HIPAA/CLIA/CAP
Hazardous specimens
Custodianship/Long-term storage

ADVANCING BIOMEDICAL RESEARCH: MULTIPLYING INVESTIGATIONS


Leveraging the Biospecimen
Biomarkers of health and disease
Translation from laboratory to clinic
Diagnostic tools
Targets for drug discovery
Tests for drug development
Clinical trials
Case studies

Using the Biospecimen
Extraction of biomolecules
Measuring quality
Fit-for-purpose
Assay development
Assay validation
Omics
Case studies

Those encouraged to submit a title and summary of their experiences for consideration of presentation include:

  • Molecular researchers utilizing biospecimens for their research
  • Biobankers providing biospecimens, developing biopreservation technologies standards and protocols, and managing resources while navigating regulatory compliance
  • R&D researchers and clinical trial professionals collecting, analyzing, and utilizing data

If you would like to submit a proposal to give a presentation at this meeting, please click here.

The deadline for priority consideration is April 6, 2018.

All proposals are subject to review by session chairmen and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

For more details on the conference, please contact:
Mary Ann Brown
Executive Director, Conferences
Cambridge Healthtech Institute
Phone: (+1) 781-972-5497 
Email: mabrown@healthtech.com

For partnering and sponsorship information, please contact:
Katelin Fitzgerald
Senior Business Development Manager
Cambridge Healthtech Institute
Phone: (+1) 781-972-5458
Email: kfitzgerald@healthtech.com